New analysis presented by the company, together with an improved discount to the price of vamorolone, mean that NICE can now ...

Bringing you our latest news, features and guidance. Subscribe for information on: our latest guidance implementation advice and case studies consultations, meetings and events the latest news, ...

A list of downloadable documents created during development.

Reason for decision Anticipate the topic will be of importance to patients, carers, professionals, commissioners and the health of the public to ensure clinical benefit is realised, inequalities in ...

Ruxolitinib for treating acute graft versus host disease refractory to corticosteroids in people aged 12 and over [ID6377] Draft guidance Technology appraisal guidance 10 January 2025 Cladribine for ...

Suggested remit: To appraise the clinical and cost effectiveness of glycopyrronium bromide cream within its marketing authorisation for treating severe primary axillary hyperhidrosis.

Tirzepatide has been shown in clinical trials to be more effective than diet and exercise support alone, and when compared ...